D-0393-2016 Class II Terminated

Recalled by Geritrex Corp — Mount Vernon, NY

FDA drug recall D-0393-2016 was initiated by Geritrex Corp on Oct 27, 2015 and is designated Class II. Reason for recall: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded. The recall status is terminated (terminated Jun 11, 2018). Affected quantity: 3,796 jars (8.4 oz) 3,204, (16.9 oz) 3,350.

Recall details

Product Type
Drugs
Report Date
Dec 9, 2015
Initiation Date
Oct 27, 2015
Termination Date
Jun 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,796 jars (8.4 oz) 3,204, (16.9 oz) 3,350

Product description

Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550

Reason for recall

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Distribution pattern

Nationwide

Code information

Lot #: a) 1201092, 1403053, 1210028, 1007059, 1112105, 1305044, 1303079, 1406098, 1407061, 1505037, 1412004 1408081, b) 1112105 & 1007036

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0393-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0393-2016. Report a data issue: hello@regdatalab.com.